A Novel PAX4 Mutation in a Japanese Patient with Maturity-Onset Diabetes of the Young
Authors:
Open Access
- 1 January 2011
- journal article
- case report
- Published by Tohoku University Medical Press in The Tohoku Journal of Experimental Medicine
- Vol. 223 (2) , 113-118
Abstract
Maturity-onset diabetes of the young (MODY) is a genetically and clinically heterogeneous type of diabetes mellitus, characterized by early onset (often before 25 years of age) and absence of pancreatic autoimmunity markers. Paired-homeodomain transcription factor 4 (PAX4) functions as a transcriptional repressor and is involved in the differentiation of insulin-secreting β-cells. Here we identified a novel PAX4 mutation in a Japanese patient with MODY. A 15-year-old, non-obese boy was admitted to our hospital because of polyuria and polydipsia. Laboratory evaluation showed an elevated fasting glucose level; however, islet cell antibodies and glutamic acid decarboxylase antibodies were not detected in the patient's serum. The proband's father had been diagnosed as having type 2 diabetes at age of 30 years. We therefore analyzed several candidate genes of MODY, and identified a novel mutation of a 39-base heterozygous deletion in exon 3 (c.374-412 del39) of PAX4 in the proband and his father. This mutation may cause exon 3 skipping that results in a frameshift, thereby producing a premature stop codon in exon 5. As this mutant PAX4 lacks a part of the homeodomain that is critical for binding to the target gene, this mutant was thought to lose the transcriptional repressor function. As expected, luciferase-reporter assays revealed that the mutant PAX4 could not repress the activities of insulin and glucagon gene promoters, unlike the wild-type PAX4 that repressed the promoter activities. The present study demonstrates that a novel mutation of PAX4 is likely to be associated with diabetes in this Japanese family.Keywords
This publication has 19 references indexed in Scilit:
- Two novel exonic point mutations in HEXA identified in a juvenile Tay-Sachs patient: Role of alternative splicing and nonsense-mediated mRNA decayMolecular Genetics and Metabolism, 2010
- PAX4Mutations in Thais with Maturity Onset Diabetes of the YoungThe Journal of Clinical Endocrinology & Metabolism, 2007
- Nonsense-mediated mRNA decay: target genes and functional diversification of effectorsTrends in Biochemical Sciences, 2006
- Molecular Genetic Analysis of MODY Candidate Genes in Japanese Patients with Non-Obese Juvenile Onset Diabetes MellitusJournal of Pediatric Endocrinology and Metabolism, 2006
- Nonsense and Missense Mutations in the Human Hepatocyte Nuclear Factor-1 Gene (TCF2) and Their Relation to Type 2 Diabetes in JapaneseThe Journal of Clinical Endocrinology & Metabolism, 2002
- An Exon Splice Enhancer Mutation Causes Autosomal Dominant GH DeficiencyThe Journal of Clinical Endocrinology & Metabolism, 2002
- Molecular Mechanisms and Clinical Pathophysiology of Maturity-Onset Diabetes of the YoungNew England Journal of Medicine, 2001
- Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseasesTrends in Biochemical Sciences, 2000
- Identification of a Portable Repression Domain and an E1A-Responsive Activation Domain in Pax4: a Possible Role of Pax4 as a Transcriptional Repressor in the PancreasMolecular and Cellular Biology, 1999
- Mutation in hepatocyte nuclear factor–1β gene (TCF2) associated with MODYNature Genetics, 1997